Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 29 (1) , 66-75
- https://doi.org/10.1016/0090-8258(88)90148-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- Immunohistochemical localization of tumor markers in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1984
- CA125-ANTIGEN LEVELS IN OBSTETRIC AND GYNECOLOGIC PATIENTS1984
- MONOCLONAL-ANTIBODY IMMUNORADIOMETRIC ASSAY FOR AN ANTIGENIC DETERMINANT (CA 125) ASSOCIATED WITH HUMAN EPITHELIAL OVARIAN CARCINOMAS1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981